EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML
Clinical trial NCT02533115 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT02533115
- Sponsor
- Jazz Pharmaceuticals
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.